Chemed Corporation to Present at the Oppenheimer 23rd Annual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYS: CHE) today announced that it will deliver a presentation at the Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13, 2012, at approximately 2:45 p.m. (ET) at the Waldorf=Astoria Hotel in New York City.
The presentation will be webcast live and can be accessed through the Investor Relations section of the Chemed website at www.chemed.com. The webcast replay will be available approximately three hours after the live event and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance.Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements.Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
Sherri L. Warner, 513-762-6683
KEYWORDS: United States North America New York Ohio
The article Chemed Corporation to Present at the Oppenheimer 23rd Annual Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.